CCM
NVS icon

Coldstream Capital Management’s Novartis NVS Stock Holding History

Coldstream Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74M Sell
17,467
-1,443
-8% -$216K 0.03% 236
2026
Q1 		$2.89M Buy
18,910
+5,586
+42% +$856K 0.04% 210
2025
Q4 		$1.84M Sell
13,324
-4,347
-25% -$569K 0.02% 307
2025
Q3 		$2.27M Buy
17,671
+4,565
+35% +$557K 0.03% 274
2025
Q2 		$1.59M Buy
13,106
+5,065
+63% +$571K 0.03% 323
2025
Q1 		$896K Buy
8,041
+277
+4% +$29.5K 0.02% 403
2024
Q4 		$756K Sell
7,764
-183
-2% -$19.5K 0.02% 444
2024
Q3 		$914K Buy
7,947
+1,109
+16% +$126K 0.02% 405
2024
Q2 		$728K Buy
6,838
+136
+2% +$13.7K 0.02% 410
2024
Q1 		$648K Buy
6,702
+307
+5% +$31.5K 0.02% 458
2023
Q4 		$646K Buy
6,395
+891
+16% +$86K 0.02% 408
2023
Q3 		$561K Sell
5,504
-517
-9% -$52.5K 0.02% 386
2023
Q2 		$608K Buy
6,021
+71
+1% +$7.1K 0.02% 380
2023
Q1 		$547K Buy
5,950
+3,085
+108% +$269K 0.02% 410
2022
Q4 		$260K Buy
+2,865
New +$241K 0.01% 666
2022
Q2 		$482K Buy
5,702
+959
+20% +$84.1K 0.02% 403
2022
Q1 		$416K Buy
4,743
+558
+13% +$48.3K 0.01% 451
2021
Q4 		$366K Buy
+4,185
New +$347K 0.01% 537

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Coldstream Capital Management's NVS Position: Q2 2026 in Review

Coldstream Capital Management reduced its Novartis (NVS) stake by 7.6% in Q2 2026, selling an estimated $216K and leaving 17,467 shares worth $2.74M. The position accounts for 0.03% of the portfolio, ranked #236.

Coldstream Capital Management first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.89M in Q1 2026. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Coldstream Capital Management held 17,467 shares of Novartis worth $2.74M as of Q2 2026.
  • Coldstream Capital Management sold 1,443 Novartis shares in Q2 2026, an estimated $216K.
  • Novartis made up 0.03% of Coldstream Capital Management's portfolio in Q2 2026, its #236 holding.
  • Coldstream Capital Management first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
  • Coldstream Capital Management's Novartis position peaked at $2.89M in Q1 2026.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.